Immune Therapy for Chronic Lymphocytic Leukemia Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond

被引：7
|
作者：
Shadman, Mazyar [1 ,2 ]
Maloney, David G. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave North,D5-396, Seattle, WA 98109 USA
[2] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 04期
关键词：
CLL; SLL; Allogeneic transplant; CAR-T therapy; Immunotherapy; LONG-TERM OUTCOMES; FOLLOW-UP; COMMITTEE; IBRUTINIB; SOCIETY; BEHALF; BLOOD;
D O I：
10.1016/j.hoc.2021.03.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：847 / 862
页数：16
相关论文
共 50 条
  • [31] Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia
    Fraietta, Joseph A.
    Lacey, Simon F.
    Orlando, Elena
    Pruteanu, Julian
    Gohil, Mercy
    Wang, Yan
    Boesteanu, Alina
    OConnor, Roddy
    Ambrose, David E.
    Hwang, Wei-Ting
    Wilcox, Nicholas
    Bedoya, Felipe
    Dorfmeier, Corin
    Chen, Fang
    Parakandi, Harit
    Gupta, Minnal
    Pequignot, Edward
    Johnson, F. Brad
    Kulikovskaya, Irina
    Liu, Li
    Lundh, Stefan M.
    Xu, Jun
    Davis, Megan M.
    Young, Regina M.
    Levine, Bruce L.
    Siegel, Don L.
    Huang, Alexander
    Wherry, E. John
    Zhou, Jing
    Paczkowski, Patrick
    Mackay, Sean
    Brogdon, Jennifer
    Bitter, Hans
    Porter, David L.
    June, Carl H.
    Melenhorst, J. Joseph
    BLOOD, 2017, 130
  • [32] Chimeric antigen receptor T-cell therapy for acute lymphocytic leukaemia: where are we in 2020?
    Laetsch, Theodore W.
    LANCET HAEMATOLOGY, 2020, 7 (11): : E778 - E779
  • [33] Cell therapy of chronic lymphocytic leukaemia: Transplants and chimeric antigen receptor (CAR)-T cells
    Yang, Shenmiao
    Huang, Xiaojun
    Gale, Robert Peter
    BLOOD REVIEWS, 2022, 51
  • [34] Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia
    Kovalovsky, Damian
    Yoon, Jeong Heon
    Cyr, Matthew G.
    Simon, Samantha
    Voynova, Elisaveta
    Rader, Christoph
    Wiestner, Adrian
    Alejo, Julie
    Pittaluga, Stefania
    Gress, Ronald E.
    LEUKEMIA, 2021, 35 (09) : 2581 - 2591
  • [35] Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia
    Damian Kovalovsky
    Jeong Heon Yoon
    Matthew G. Cyr
    Samantha Simon
    Elisaveta Voynova
    Christoph Rader
    Adrian Wiestner
    Julie Alejo
    Stefania Pittaluga
    Ronald E. Gress
    Leukemia, 2021, 35 : 2581 - 2591
  • [36] Chimeric antigen receptor t-cell therapy in the czech republic
    Folber, F.
    Pytlik, R.
    Polgarova, K.
    Sramkova, L.
    Sramek, J.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 138 - 139
  • [37] Chimeric Antigen Receptor T-Cell Therapy: Are Neuroradiologists Prepared?
    Nabavizadeh, S. A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2019, 40 (10) : E52 - E52
  • [38] Chimeric antigen receptor T-cell therapy for HIV cure
    Alfageme-Abello, Oscar
    Porret, Raphael
    Perreau, Matthieu
    Perez, Laurent
    Muller, Yannick D.
    CURRENT OPINION IN HIV AND AIDS, 2021, 16 (02) : 88 - 97
  • [39] Cytokine signaling in chimeric antigen receptor T-cell therapy
    Kagoya, Yuki
    INTERNATIONAL IMMUNOLOGY, 2024, 36 (02) : 49 - 56
  • [40] Chimeric antigen receptor T-cell therapy in autoimmune diseases
    Liu, Jie
    Zhao, Yan
    Zhao, Hai
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345